Drugs News and Research

RSS

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

The prevalence of skin disease exceeds that of obesity, hypertension or cancer. One in three individuals in the United States suffers with a skin disease, with ~2-3% of the American population suffering from psoriasis.

27 Sep 2013

BD, WHO commit to develop and launch Odon Device for assisted delivery of newborns

BD, a leading global medical technology company, and the World Health Organization, together with Saving Lives at Birth: A Grand Challenge for Development partners, today announced a commitment to develop and launch the Odon Device, an innovative new obstetrical instrument for assisting the delivery of newborns during circumstances of troublesome labor.

From BD (Becton, Dickinson and Company) 27 Sep 2013

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Tremelimumab, one of a new class of immunomodulatory monoclonal antibodies, has shown encouraging clinical activity and acceptable tolerability in patients with chemotherapy-resistant malignant mesothelioma, results of a single-arm phase II study show.

27 Sep 2013

Sister stem cells display considerable differences despite having identical DNA

Scientists have used a brand new technique for examining individual stem cells to uncover dramatic differences in the gene expression levels - which genes are turned 'up' or 'down'- between apparently identical 'sister' pairs.

27 Sep 2013

House and Senate negotiators reaching agreement on compounding pharmacy legislation

The measure would apply uniform national standards to pharmacy compounding while enacting a track-and-trace system to ensure the safety of drugs throughout the supply chain.

27 Sep 2013

Intestinal mucus potentially improves life of people suffering from inflammatory bowel disease

Researchers at Institut Hospital del Mar d'Investigacions M-diques (IMIM) in Barcelona, in collaboration with the Icahn School of Medicine at Mount Sinai in New York and other U.S. Institutions, have found that intestinal mucus not only acts as a physical barrier against commensal bacteria and dietary antigens, but also prevents the onset of inflammatory reactions against these agents.

27 Sep 2013

New class of antidepressants appears potentially effective in combating deadly form of lung cancer

A little-used class of antidepressants appears potentially effective in combating a particularly deadly form of lung cancer, according to a new study from researchers at the Stanford University School of Medicine.

27 Sep 2013

New public resource to help researchers explore data from the NIH human microbiome project

The National Institutes of Health (NIH) has launched the first phase of the Microbiome Cloud Project (MCP), a collaboration with Amazon Web Services that aims to improve access to and analysis of data from the Human Microbiome Project (HMP).

27 Sep 2013

Mayo Clinic experts to discuss risk factors, screening and treatments for breast cancer

October is National Breast Cancer Awareness Month, and Mayo Clinic breast cancer experts are available to discuss risk factors, screening and treatments.

27 Sep 2013

Study: Antidepressant drugs prove to be effective against SCLC patients

A bioinformatics approach to repurposing drugs resulted in identification of a class of antidepressants as a potential new treatment for small-cell lung cancer (SCLC), according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

27 Sep 2013

Study shows certain brain cells play critical role in anorexia, bulimia, and binge eating disorder

Sixty years ago scientists could electrically stimulate a region of a mouse's brain causing the mouse to eat, whether hungry or not. Now researchers from UNC School of Medicine have pinpointed the precise cellular connections responsible for triggering that behavior.

27 Sep 2013

'Jekyll-and-Hyde' protein could be potent target for developing new cancer drugs

The mood changes of a 'Jekyll-and-Hyde' protein, which sometimes boosts tumour cell growth and at other times suppresses it, have been explained in a new study led by Oxford University researchers.

27 Sep 2013

Experiments with neutrons show antidepressant lithium accumulates strongly in white matter of the brain

At present lithium is most popular for its use in rechargeable batteries. But for decades now, lithium has also been used to treat various psychological diseases such as depressions, manias and bipolar disorders. But, the exact biological mode of action in certain brain regions has hardly been understood. It is well known that lithium lightens moods and reduces aggression potential.

27 Sep 2013

Drug misuse predicts protracted hospital stay for schizophrenia patients

Patients hospitalized with schizophrenia have more severe symptoms and spend longer in hospital if they have a concurrent substance use disorder, report researchers.

26 Sep 2013

Anti-inflammatory drug ibuprofen may fight against certain cancers

Latest research by scientists at the University of Bath has shown why the anti-inflammatory drug ibuprofen might stop certain cancers from developing.

26 Sep 2013

Astellas Pharma US, Medivation report results of advanced prostate cancer patient, caregiver survey

Astellas Pharma US, Inc. and Medivation, Inc. today announced results of a national survey of men with advanced prostate cancer and caregivers of men with advanced prostate cancer.

26 Sep 2013

Alliqua enters into distribution agreement with Carolon Health Care Products

Alliqua Inc., a biomedical company offering a suite of drug delivery technologies and wound healing solutions, has entered into an agreement with Carolon Health Care Products through which it will gain both new sales distribution pathways and established customers.

26 Sep 2013

Lumena Pharmaceuticals initiates LUM001 clinical program in children with ALGS

Lumena Pharmaceuticals, a company developing oral therapeutics for rare liver diseases, today announced the initiation of a global clinical program to evaluate its drug candidate LUM001 in children with Alagille syndrome. The first patient has been dosed in the IMAGO Phase II study being conducted in the U.K., and enrollment of pediatric patients is expected to begin later this year in the ITCH Phase II study in the U.S.

26 Sep 2013

Viewpoints: Health law premium rates reveal 'mostly good news' but renew critics arguments; 'Cruz-ing for a bruising;'

President Obama, President Clinton, and Senator Ted Cruz all spent a lot of time talking about Obamacare on Tuesday. But the real news came just as the day was ending, right at midnight, when the Department of Health and Human Services released data on insurance premiums available through the new Obamacare marketplaces. Several states had already released their data. With this report, HHS provided premium information for most of the rest. Overall, the numbers are pretty consistent with previous reports, albeit with some new and interesting wrinkles. It seems like mostly good news, though the law's critics would argue it vindicates some of their arguments, as well (Jonathan Cohn, 9/25).

26 Sep 2013

Ohio State's Heart and Vascular Center names Garret FitzGerald as recipient of Schottenstein Prize

The Ohio State University Wexner Medical Center's Heart and Vascular Center has named Dr. Garret FitzGerald, professor of Medicine and Pharmacology; chair of the Department of Pharmacology and director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine at University of Pennsylvania, the recipient of the 2013 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.

26 Sep 2013

Drugs News and Research

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

BD, WHO commit to develop and launch Odon Device for assisted delivery of newborns

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Sister stem cells display considerable differences despite having identical DNA

House and Senate negotiators reaching agreement on compounding pharmacy legislation

Intestinal mucus potentially improves life of people suffering from inflammatory bowel disease

New class of antidepressants appears potentially effective in combating deadly form of lung cancer

New public resource to help researchers explore data from the NIH human microbiome project

Mayo Clinic experts to discuss risk factors, screening and treatments for breast cancer

Study: Antidepressant drugs prove to be effective against SCLC patients

Study shows certain brain cells play critical role in anorexia, bulimia, and binge eating disorder

'Jekyll-and-Hyde' protein could be potent target for developing new cancer drugs

Experiments with neutrons show antidepressant lithium accumulates strongly in white matter of the brain

Drug misuse predicts protracted hospital stay for schizophrenia patients

Anti-inflammatory drug ibuprofen may fight against certain cancers

Astellas Pharma US, Medivation report results of advanced prostate cancer patient, caregiver survey

Alliqua enters into distribution agreement with Carolon Health Care Products

Lumena Pharmaceuticals initiates LUM001 clinical program in children with ALGS

Viewpoints: Health law premium rates reveal 'mostly good news' but renew critics arguments; 'Cruz-ing for a bruising;'

Ohio State's Heart and Vascular Center names Garret FitzGerald as recipient of Schottenstein Prize

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News